Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydrox

Details Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydrox Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydrox

1994-07-12

1995-07-11

Tsang, Cecilia

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

544298, A61K 31505, C07D23902

Patent

active

054321816

ABSTRACT:
The present invention is novel compounds which are 4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidine substituted 1,2,4- and 1,3,4-thiadiazoles and oxadiazoles, and 1,2,4-triazoles, and pharmaceutically acceptable additions and base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are now found to have activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever, and particularly rheumatoid arthritis, osteoarthritis, other inflammatory conditions, psoriasis, allergic diseases, asthma, inflammatory bowel disease, GI ulcers, cardiovascular conditions, including ischemic heart disease and atherosclerosis, and ischemia-induced cell damage, particularly brain damage caused by stroke. They can also be used topically for treating acne, sunburn, psoriasis, and eczema. Also included are leukotriene mediated pulmonary, gastrointestinal, inflammatory, dermatological, and cardiovascular conditions. The disclosed compounds also have potential utility as antioxidants. The preferred use is in treating inflammatory conditions.

REFERENCES:
patent: 4711888 (1987-12-01), Walker et al.
patent: 4859679 (1989-08-01), Santini
patent: 4940712 (1990-07-01), Walker et al.
patent: 5177079 (1993-01-01), Connor et al.
Derwent Abstract of EP 31970 (Pfizer Inc.) 17 Nov. 1988.
Derwent Abstractof EP 233461 (American Cyanamid Co.) 13 Jan. 1986.
Derwent Abstract of JP 1216978 (Wako Pure Chem. Ind. KK) 26 Feb. 1988.
Derwent Abstract of BE 881752 (Soc. Etud. Prod. Chim.) 10 Mar. 1979.
Chem. Ber., 1960, pp. 1998-2001, Dornow et al.
Chemical Reviews, 1975, vol. 75, No. 4, p. 207 and p. 412.
J. C. S. Perkin I, 1976, pp. 1202-1204, Roeterdink et al.
J. Med Chem., 1990, 33, pp. 1892-1989, Lazer et al.
Indian Journal of Chemistry, vol. 24B, May 1985, pp. 535-538, Sen et al.
Biochem., 1951, 48, pp. 400-406, Bray et al.

Affiliated with

Also associated with

Rating

Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydrox does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydrox, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted heteroaryl analogs of 4,6-di-tertiary-butyl-5-hydrox will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-503634